中华医学科研管理杂志
中華醫學科研管理雜誌
중화의학과연관리잡지
ZHONGHUA YIXUE KEYAN GUANLI ZAZHI CHINESE JOURNAL OF MEDICAL SCIENCE RESEARCH MANAGEMENT
2013年
5期
封2-封4,360
,共2页
陈海珍%沈康%吴徐明%杨俐萍%陈建国
陳海珍%瀋康%吳徐明%楊俐萍%陳建國
진해진%침강%오서명%양리평%진건국
肿瘤%流行病学%生物样本%信息管理%南通
腫瘤%流行病學%生物樣本%信息管理%南通
종류%류행병학%생물양본%신식관리%남통
Neoplasm%Epidemiology%Bio-specimen%Information management%Nantong
肿瘤医院具有独特的资源优势.利用临床流行病学方法,收集、利用肿瘤病例信息、肿瘤临床诊治、肿瘤生物标本等信息资源,可以促进新形势下肿瘤医院管理和科研的深入发展.南通市肿瘤医院是三甲肿瘤专科医院,也是国内最早开展肿瘤诊治的地市级肿瘤专科医院之一,已具备了开展临床流行病学研究、医学随访研究及完善样本库并应用的工作基础.本文内容包括建立以医院为基础的肿瘤登记系统、为开展临床流行病学服务;建立临床肿瘤病例的随访与调查制度,评估肿瘤治疗影响因素并开展生存率分析;建立具有完善流行病学信息背景的肿瘤病例生物标本库,以适应转化医学发展之需.对工作中存在的瓶颈问题也进行了讨论.
腫瘤醫院具有獨特的資源優勢.利用臨床流行病學方法,收集、利用腫瘤病例信息、腫瘤臨床診治、腫瘤生物標本等信息資源,可以促進新形勢下腫瘤醫院管理和科研的深入髮展.南通市腫瘤醫院是三甲腫瘤專科醫院,也是國內最早開展腫瘤診治的地市級腫瘤專科醫院之一,已具備瞭開展臨床流行病學研究、醫學隨訪研究及完善樣本庫併應用的工作基礎.本文內容包括建立以醫院為基礎的腫瘤登記繫統、為開展臨床流行病學服務;建立臨床腫瘤病例的隨訪與調查製度,評估腫瘤治療影響因素併開展生存率分析;建立具有完善流行病學信息揹景的腫瘤病例生物標本庫,以適應轉化醫學髮展之需.對工作中存在的瓶頸問題也進行瞭討論.
종류의원구유독특적자원우세.이용림상류행병학방법,수집、이용종류병례신식、종류림상진치、종류생물표본등신식자원,가이촉진신형세하종류의원관리화과연적심입발전.남통시종류의원시삼갑종류전과의원,야시국내최조개전종류진치적지시급종류전과의원지일,이구비료개전림상류행병학연구、의학수방연구급완선양본고병응용적공작기출.본문내용포괄건립이의원위기출적종류등기계통、위개전림상류행병학복무;건립림상종류병례적수방여조사제도,평고종류치료영향인소병개전생존솔분석;건립구유완선류행병학신식배경적종류병례생물표본고,이괄응전화의학발전지수.대공작중존재적병경문제야진행료토론.
The tumor hospital has its unique resources superiority.To collect and utilize the information from tumor patients,information from their diagnosis and treatment,and biological specimens,through clinical epidemiology methods and design,would facilitate the deep development in the management and research at tumor hospitals in the new circumstances.Nantong Tumor Hospital,a first rate 3A hospital,and also one of the earliest-run specialized tumor hospitals in prefecture-level cities,possesses own basis for clinical epidemiological research,medical follow-up,and application of biobanking.In this paper we report the specific work plan and work contents,including:to establish a hospital-based cancer registry system for serving clinical epidemiology; to set up a follow-up system for clinical cases with tumor,in order to assess the effect of factors on tumor treatment and to analyse their survival rates; to build a biobank of tumor cases with perfect epidemiological information and background,fitting in with the needs of the development of translational medicine.The bottleneck problems in the work are also discussed.